Moderna (MRNA) closed at $40.60 in the latest trading session, marking a +2.52% move from the prior day. The stock's change was more than the S&P 500's daily loss of 0.53%. Meanwhile, the Dow lost ...

SAN FRANCISCO — Despite all the hopeful chatter about the life sciences industry making a rebound after a multiyear ...

Moderna shares surge 30% in 2026 on raised revenue forecast and cost cuts. Technical breakout suggests continued momentum ...

At the 44 th Annual JP Morgan Healthcare Conference on Monday, Moderna Inc. (NASDAQ:MRNA) said that it expects to report ...

Moderna pivots to infectious disease & oncology, targeting cash break-even by 2028. Click here to see why I rate MRNA stock a ...

Moderna Inc.’s chairman says the Trump administration’s vaccine policy changes are part of a broader attack on science that ...

Moderna (MRNA) has reiterated its target of up to 10% revenue growth in 2026, supported by a strategy to build a large ...

Jan 12 (Reuters) - Moderna said on Monday ‌it ​expects to report around $1.9  billion in ‌sales for 2025, putting it near the ...

Bayer's Monsanto sued COVID-19 vaccine makers Pfizer , BioNTech and Moderna in Delaware federal court on Tuesday for ...

The NFL Week 17 schedule rolls on with 10 games on Sunday and then the standard 'Monday Night Football' slot. Several of the remaining games have a direct bearing on the NFL playoffs and seeding. In ...

CHICAGO (WLS) -- The Transportation Security Administration expects 2025 to be another record-setting year for holiday travel. Nearly 1,000 flights were canceled nationwide as of Saturday evening, but ...

Initiate Moderna with a Hold rating at a $25 target price (lower than the current price), citing balanced risk-reward despite the advanced mRNA platform and robust pipeline. MRNA's near-term execution ...